BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder characterized by epistaxis, arteriovenous malformations, and telangiectases. The majority of the patients have a mutation in the coding region of the activin A receptor type II-like 1 (ACVRL1) or Endoglin (ENG) gene. However, in approximately 15% of cases, sequencing analysis and deletion/duplication testing fail to identify mutations in the coding regions of these genes. Knowing its vital role in transcription and translation control, we were prompted to investigate the 5'untranslated region (UTR) of ENG. METHODS AND RESULTS: We sequenced the 5'UTR of ENG for 154 HHT patients without mutations in ENG or ACVRL1 coding regions. We found a mutation (c.-127C > T), which is predicted to affect translation initiation and alter the reading frame of endoglin. This mutation was found in a family with linkage to the ENG, as well as in three other patients, one of which had an affected sibling with the same mutation. In vitro expression studies showed that a construct with the c.-127C > T mutation alters the translation and decreases the level of the endoglin protein. In addition, a c.-9G > A mutation was found in three patients, one of whom was homozygous for this mutation. Expression studies showed decreased protein levels suggesting that the c.-9G > A is a hypomorphic mutation. CONCLUSIONS: Our results emphasize the need for the inclusion of the 5'UTR region of ENG in clinical testing for HHT.
5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia.
ENG 基因 5'UTR 突变会导致遗传性出血性毛细血管扩张症
阅读:5
作者:Damjanovich Kristy, Langa Carmen, Blanco Francisco J, McDonald Jamie, Botella Luisa M, Bernabeu Carmelo, Wooderchak-Donahue Whitney, Stevenson David A, Bayrak-Toydemir Pinar
| 期刊: | Orphanet Journal of Rare Diseases | 影响因子: | 3.500 |
| 时间: | 2011 | 起止号: | 2011 Dec 22; 6:85 |
| doi: | 10.1186/1750-1172-6-85 | 研究方向: | 其它 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
